.jpg)
STAT+: Gilead drug prolongs survival of women with common form of breast cancer
Gilead Sciences said Wednesday that its cancer drug Trodelvy prolonged the survival of women with…
Author: STAT
Relay Therapeutics drug shows promise in early trial
A daily dose of Relay Therapeutics’ experimental drug for cholangiocarcinoma, a rare cancer of the…
STAT+: UnitedHealth signs a deal with Walmart for a new Medicare Advantage plan
UnitedHealth Group is poised to widen its lead in the Medicare Advantage market through a…
Judge invalidates parts of the ACA that mandate health coverage of many preventive services and drugs
A federal judge in Texas has ruled that parts of the Affordable Care Act mandating…
Stress and depression are better long Covid indicators than physical comorbidities, new study says
Studies have repeatedly suggested that physical conditions like immunosuppression and hypertension can increase a person’s…
Prehistoric skeleton reveals oldest surgical amputation — in a hunter-gatherer society 31,000 years ago
The amputation happened when the individual was perhaps 12 years old, the skeleton indicates. Gone…
STAT+: Pharmalittle: FDA holds rare second meeting over an ALS drug; U.S. to expand distribution for monkeypox vaccine
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy
Good Therapeutics, a private company that raised just $30 million in venture financing since its…
Opinion: Congress should not compel Medicare to pay for liquid biopsies
When the two Republican senators from Mississippi cosponsor legislation with the two Democratic senators from…
Opinion: Listen: A doctor with ALS laments the slow pace for drug approval
During his long career as a pediatric oncologist and cancer researcher, William Woods thought highly…
As masks are shed, a routine visit to a medical office can pose Covid risks for some patients
In May, Sarah Fama had to get blood work done before refilling a prescription for…
Opinion: The FDA needs to be more flexible in assessing treatments for rare diseases, like the one that seemed to help my son
Every time I read about clinical trials testing possible treatments for rare diseases, I think…
STAT+: Tobacco giant Philip Morris is investing billions in health care. Critics say it’s peddling cures for its own poison
A new health care company was quietly incorporated last month, with plans to leverage cutting-edge…
STAT+: Pharma donations to patient charities may violate the ‘spirit’ of anti-kickback laws
There is a federal law that prohibits drug companies from directly covering out-of-pocket spending by…
STAT+: Amazon health feature can accurately assess users’ mobility, study finds
As Amazon works to shoulder its way into health care, a new study — funded…
Juul to pay nearly $440M to settle states’ teen vaping probe
HARTFORD, Conn. — Electronic cigarette maker Juul Labs has agreed to pay nearly $440 million…
STAT+: Why Illumina has a merger mess of it own making
For Illumina, the leading maker of DNA sequencing equipment, there was bad news and worse…
White House signals most people will only need annual Covid booster
As part of its push to encourage vaccine-weary Americans to get the updated Covid shot,…
STAT+: Bayer agrees to $40 million settlement over kickbacks and downplaying drug safety risks
After nearly two decades of litigation, Bayer agreed to pay $40 million to settle a…
Google debuts a new AI tool in the global fight against tuberculosis
Tuberculosis kills 1.4 million people every year, primarily in places where poverty and deprivation conspire…
STAT+: Pharmalittle: Illumina deal for Grail is blocked after EU veto; CVS buys Signify to expand into house calls
Good morning, everyone, and nice to see you again after a much-welcomed and extended break…
Opinion: Open access to research can close gaps for people with disabilities
In a long-overdue move, the federal Office of Science and Technology Policy has issued guidance…
STAT+: Doctors, seniors groups flag concerns with Medicare Advantage
Doctors, patients, and seniors groups are airing new grievances about Medicare Advantage, arguing the growing…
Opinion: The FDA got it right with hearing aids. Updating Medicare coverage is next
“You would really benefit from hearing aids, but they aren’t covered by Medicare and cost…
What happens to patients when telehealth businesses shutter?
Buzzy, venture-backed startups and big tech companies that have promised to disrupt health care are…
STAT+: How a tool to map computer viruses came to power biology research
When mathematicians Leland McInnes and John Healy walked into their work’s annual “Big Dig” —…
Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies
WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems…
Opinion: Dying of a disease I never knew existed
By this time next year, if the medical forecasts are correct, I will probably be…
New Covid vaccines are hitting pharmacy shelves. What happens to the original shots?
WASHINGTON — Senior Biden officials are in discussions about what to do with millions of…
Study raises concerns about the effectiveness of the monkeypox vaccine
A new study is raising concerns about the effectiveness of the monkeypox vaccine being used…
STAT+: Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics
Good morning, everyone. I’m Jason Mast, the last of the understudies filling in while Ed…
Opinion: People with terminal cancer need to know they are dying. Doctors shouldn’t withhold that information
I have worn many hats professionally. The most uncomfortable one is “doctor friend.” At best,…
Opinion: Prediction markets and the future of Covid-19
Forecasters have used all sorts of tools to gauge where the U.S. and the world…
Rahul Gupta, first physician to serve as drug czar, says stigma among doctors is key culprit in addiction crisis
WASHINGTON — Rahul Gupta is no stranger to the nationwide addiction crisis. Drug use and…
Your questions on the new Covid vaccine boosters answered
Sometime this weekend or early next week, pharmacies and doctors’ offices are going to start…
CDC advisory panel backs updated Covid-19 boosters
An expert committee that advises the Centers for Disease Control and Prevention on vaccine policy…
STAT+: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade…
Listen: The anti-aging research boom, the Godfather of biotech, & the future of Biogen
What can worms teach us about immortality? How does one become the Godfather? And where…
STAT+: Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics
Good morning. This is Jonathan with you once more. We’re now close enough to the…
Opinion: Public health needs to be transformed. Health IT can help
Covid-19 pummeled public health agencies and organizations. Future crises, whether from infectious disease, extreme weather,…
A Q&A with WHO’s Maria Van Kerkhove on Covid — and fatigue over the pandemic
Maria Van Kerkhove gets it. Truly, she knows you’re over Covid. The World Health Organization’s…
Opinion: ‘Food is medicine’ interventions should be the main course at White House nutrition conference
Much of the public’s perceptions around food as an intervention for health are dated. So…
A third Covid autumn is upon us. Here’s a look at where we stand
As the country heads for its third autumn and winter with Covid-19, the forecasts are…
STAT+: Calm’s head of science departs amid a shakeup at meditation app maker
In 2021, Jennifer Huberty left her post in academia to become the first full-time head…
The Biden administration is pushing another round of Covid boosters. Who’s listening?
WASHINGTON — Federal health officials are starting to push new, variant-targeting vaccines that they say…
FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains
The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and…
STAT+: Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year
Good morning from San Diego. I’m Jonathan Wosen, STAT’s West Coast biotech reporter, and I’m…
Opinion: As hospitals raise their prices, U.S. workers and businesses suffer
Despite a recent taxpayer-subsidized boon, the hospital industry spent the last several months lobbying for…
STAT+: One Medical founder Tom Lee on the Amazon deal and striking the right balance with virtual care
Virtual care companies face increasing churn as telehealth visits sink below their pandemic-era peak, forcing…
Opinion: The No Surprises Act: A Band-Aid protecting business as usual
The No Surprises Act has been hailed as a major bipartisan reform aiming to eliminate…